Cortical injury increases cholesterol 24S hydroxylase (Cyp46) levels in the rat brain

Journal of Neurotrauma

Volumn 25, Issue 9, 2008, Pages 1087-1098

  Cartagena, Casandra M ^a   Ahmed, Farid ^a   Burns, Mark P ^a   Pajoohesh Ganji, Ahdeah ^a   Pak, Daniel T ^a   Faden, Alan I ^a   Rebeck, G William ^a  

^a GEORGETOWN UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Glia cell response to injury; Neurodegenerative disorders; Traumatic brain injury

Indexed keywords

ABC TRANSPORTER A1; APOLIPOPROTEIN E; CHOLESTEROL; CHOLESTEROL 24S HYDROXYLASE; CHOLESTEROL DERIVATIVE; LIVER X RECEPTOR; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELL TYPE; CONTROLLED STUDY; ENZYME REGULATION; GENE ACTIVATION; GENETIC TRANSCRIPTION; GLIA CELL; HOMEOSTASIS; IMMUNOHISTOCHEMISTRY; MALE; MICROGLIA; NERVE CELL; NONHUMAN; NUCLEOTIDE SEQUENCE; PERCUSSION; PROTEIN EXPRESSION; RAT; TRAUMATIC BRAIN INJURY; WESTERN BLOTTING;

ANIMALS; APOLIPOPROTEINS E; ATP-BINDING CASSETTE TRANSPORTERS; BLOTTING, WESTERN; BRAIN INJURIES; CEREBRAL CORTEX; FLUORESCENT ANTIBODY TECHNIQUE; IMMUNOHISTOCHEMISTRY; MALE; MICROGLIA; NEURONS; RATS; RATS, SPRAGUE-DAWLEY; STEROID HYDROXYLASES;

EID: 51849165680     PISSN: 08977151     EISSN: None     Source Type: Journal    
DOI: 10.1089/neu.2007.0444     Document Type: Article

References (63)

1. Akiyama, H., Barger, S., Barnum, S., Bradt, B., Bauer, J., Cole, G. M., Cooper, N. R., Eikelenboom, P., Emmerling, M., Fiebich, B.L., Finch, C.E., Frautschy, S., Griffin, W.S., Hampel, H., Hull, M., Landreth, G., Lue, L., Mrak, R., Mackenzie, I.R., McGeer, P.L., O'Banion, M.K., Pachter, J., Pasinetti, G., Plata-Salaman, C., Rogers, J., Rydel, R., Shen, Y., Streit, W., Strohmeyer, R., Tooyoma, I., Van Muiswinkel, F.L., Veerhuis, R., Walker, D., Webster, S., Wegrzyniak, B., Wenk, G., and Wyss-Coray, T. (2000). Inflammation and Alzheimer's disease. Neurobiol Aging. 21, 383-421.
2. Alexandrov, P., Cui, J., Zhao, Y., and Lukiw, W.J. (2005). 24S-Hydroxycholesterol induces inflammatory gene expression in primary human neural cells. Neuroreport 16, 909-913.
3. Ansell, B.J., Fonarow, G.C., Navab, M., and Fogelman, A M. (2007). Modifying the anti-inflammatory effects of high-density lipoprotein. Curr. Atheroscler. Rep. 9, 57-63.
4. Bar-On, P., Crews, L., Koob, A.O., Mizuno, H., Adame, A., Spencer, B., and Masliah, E. (2008). Statins reduce neuronal alpha-synuclein aggregation in in vitro models of Parkinson's disease. J. Neurochem. 105, 1656-1667.
5. Bogdanovic, N., Bretillon, L., Lund, E.G., Diczfalusy, U., Lannfelt, L., Winblad, B., Russell, D.W., and Bjorkhem, I. (2001). On the turnover of brain cholesterol in patients with Alzheimer's disease. Abnormal induction of the cholesterol-catabolic enzyme CYP46 in glial cells. Neurosci. Lett. 314, 45-48.
6. Bonotis, K., Krikki, E., Holeva, V., Aggouridaki, C., Costa, V., and Baloyannis, S. (2008). Systemic immune aberrations in Alzheimer's disease patients. J. Neuroimmunol. 193, 183-187.
7. Bretillon, L., Diczfalusy, U., Bjorkhem, I., Maire, M.A., Martine, L., Joffre, C., Acar, N., Bron, A., and Creuzot-Garcher, C. (2007). Cholesterol-24S-hydroxylase (CYP46A1) is specifically expressed in neurons of the neural retina. Curr. Eye Res. 32, 361-366.
8. Brown III, J., Theisler, C., Silberman, S., Magnuson, D., Gootardi-Littell, N., Lee, J.M., Yager, D., Crowley, J., Sambamuri, K., Rahman, M.M., Reiss, A.B., Eckman, C.B., and Wolozin, B. (2004). Differential expression of cholesterol hydroxylases in Alzheimer's disease. J. Biol. Chem. 279, 34674-34681.
9. Cernak, I., Vink, R., Zapple, D.N., Cruz, M.I., Ahmed, F., Chang, T., Fricke, S.T., and Faden, A.I. (2004). The pathobiology of moderate diffuse traumatic brain injury as identified using a new experimental model of injury in rats. Neurobiol. Dis. 17, 29-43.
10. Di Giovanni, S., Movsesyan, V., Ahmed, F., Cernak, I., Schinelli, S., Stoica, B., and Faden, A.I. (2005). Cell cycle inhibition provides neuroprotection and reduces glial proliferation and scar formation after traumatic brain injury. Proc. Natl. Acad. Sci. USA 102, 8333-8338.
11. Faden, A.I. (1996). Pharmacologic treatment of acute traumatic brain injury. JAMA 276, 569-570.
12. Faden, A.I., Knoblach, S.M., Cernak, I., Fan, L., Vink, R., Araldi, G.L., Fricke, S.T., Roth, B.L., and Kozikowski, A.P. (2003). Novel diketopiperazine enhances motor and cognitive recovery after traumatic brain injury in rats and shows neuroprotection in vitro and in vivo. J. Cereb. Blood Flow Metab. 23, 342-354.
13. Fagan, A.M., Watson, M., Parsadanian, M., Bales, K.R., Paul, S.M., and Holtzman, D.M. (2002). Human and murine ApoE markedly alters A beta metabolism in a mouse model of Alzheimer's disease. Neurobiol. Dis. 9, 305-318.
14. Fassbender, K., Simon, M., Bergmann, C., Stroick, M., Lutjohann, D., Keller, P., Runz, H., Bertsch, T., von Bergmann, K., Hennerici, M., Beyreuther, K., and Hartmann, T. (2001). Simvastatin strongly reduces levels of Alzheimer's disease beta-amyloid peptides A beta 42 and A beta 40 in vitro and in vivo. Proc. Natl. Acad. Sci. USA 98, 5856-5861.
15. Fitch, M.T., Doller, C., Combs, C.K., Landreth, G.E., and Silver, J. (1999). Cellular and molecular mechanisms of glial scarring and progressive cavitation: in vivo and in vitro analysis of inflammation-induced secondary injury after CNS trauma. J. Neurosci. 19, 8182-8198.
16. Fukumoto, H., Deng, A., Irizarry, M.C., Fitzgerald, M.L., and Rebeck, G.W. (2002). Induction of the cholesterol transporter ABCA1 in central nervous system cells by liver X receptor agonists increases secreted A beta levels. J. Biol. Chem. 277, 48508-48513.
17. Gasparovic, C., Rosenberg, G.A., Wallace, J.A., Estrada, E.Y., Roberts, K., Pastuszyn, A., Ahmed, W., and Graham, G.D. (2001). Magnetic resonance lipid signals in rat brain after experimental stroke correlate with neutral lipid accumulation. Neurosci. Lett. 301, 87-90.
18. Goldman, S.M., Tanner, C.M., Oakes, D., Bhudhikanok, G.S., Gupta, A., and Langston, J.W. (2006). Head injury and Parkinson's disease risk in twins. Ann. Neurol. 60, 65-72.
19. Guo, L., LaDu, M.J., and Van Eldik, L.J. (2004). A dual role for apolipoprotein E in neuroinflammation: anti- and pro-inflammatory activity. J. Mol. Neurosci. 23, 205-212.
20. Hansson, G.K., Robertson, A.K., and Soderberg-Naucler, C. (2006). Inflammation and atherosclerosis. Annu. Rev. Pathol. 1, 297-329.
21. He, X., Jenner, A.M., Ong, W.Y., Farooqui, A.A., and Patel, S.C. (2006). Lovastatin modulates increased cholesterol and oxysterol levels and has a neuroprotective effect on rat hippocampal neurons after kainate injury. J. Neuropathol. Exp. Neurol. 65, 652-663.
22. Hoane, M.R., Pierce, J.L., Holland, M.A., Birky, N.D., Dang, T., Vitek, M.P., and McKenna, S.E. (2007). The novel apolipoprotein E-based peptide COG1410 improves sensorimotor performance and reduces injury magnitude following cortical contusion injury. J. Neurotrauma 24, 1108-1118.
23. Joseph, S.B., Castrillo, A., Laffitte, B.A., Mangelsdorf, D.J., and Tontonoz, P. (2003). Reciprocal regulation of inflammation and lipid metabolism by liver X receptors. Nat. Med. 9, 213-219.
24. Jurevics, H., and Morell, P. (1995). Cholesterol for synthesis of myelin is made locally, not imported into brain. J. Neurochem. 64, 895-901.
25. Kamada, H., Sato, K., Iwai, M., Zhang, W.R., Nagano, I., Manabe, Y., Shoji, M., and Abe, K. (2003). Temporal and spatial changes of free cholesterol and neutral lipids in rat brain after transient middle cerebral artery occlusion. Neurosci. Res. 45, 91-100.
26. Kay, A.D., Day, S.P., Kerr, M., Nicoll, J.A., Packard, C.J., and Caslake, M.J. (2003). Remodeling of cerebrospinal fluid lipoprotein particles after human traumatic brain injury. J. Neurotrauma 20, 717-723.
27. Kim, H.J., Fan, X., Gabbi, C., Yakimchuk, K., Parini, P., Warner, M., and Gustafsson, J.A. (2008). Liver X receptor beta (LXR-beta): a link between beta-sitosterol and amyotrophic lateral sclerosis-Parkinson's dementia. Proc. Natl. Acad. Sci. USA 105, 2094-2099.
28. Langley, B., and Ratan, R.R. (2004). Oxidative stress-induced death in the nervous system: cell cycle dependent or independent? J. Neurosci. Res. 77, 621-629.
29. Langlois, J.A., Rutland-Brown, W., and Thomas, K.E. (2004). Traumatic Brain Injury in the United States: Emergency Department Visits, Hospitalizations, and Deaths. Centers for Disease Control and Prevention, National Center for Injury Prevention and Control: Atlanta.
30. Laskowitz, D.T., McKenna, S.E., Song, P., Wang, H., Durham, L., Yeung, N., Christensen, D., and Vitek, M.P. (2007). COG1410, a novel apolipoprotein E-based peptide, improves functional recovery in a murine model of traumatic brain injury. J. Neurotrauma 24, 1093-1107.
31. Lehmann, J.M., Kliewer, S.A., Moore, L.B., Smith-Oliver, T.A., Oliver, B.B., Su, J.L., Sundseth, S.S., Winegar, D.A., Blanchard, D.E., Spencer, T.A., and Willson, T.M. (1997). Activation of the nuclear receptor LXR by oxysterols defines a new hormone response pathway. J. Biol. Chem. 272, 3137-3140.
32. Liang, Y., Lin, S., Beyer, T.P., Zhang, Y., Wu, X., Bales, K.R., De-Mattos, R.B., May, P.C., Li, S.D., Jiang, X.C., Eacho, P.I., Cao, G., and Paul, S.M. (2004). A liver X receptor and retinoid X receptor heterodimer mediates apolipoprotein E expression, secretion and cholesterol homeostasis in astrocytes. J. Neurochem. 88, 623-634.
33. Lund, E.G., Guileyardo, J.M., and Russell, D.W. (1999). cDNA cloning of cholesterol 24-hydroxylase, a mediator of cholesterol homeostasis in the brain. Proc. Natl. Acad. Sci. USA 96, 7238-7243.
34. Lund, E.G., Xie, C., Kotti, T., Turley, S.D., Dietschy, J.M., and Russell, D.W. (2003). Knockout of the cholesterol 24-hydroxylase gene in mice reveals a brain-specific mechanism of cholesterol turnover. J. Biol. Chem. 278, 22980-22988.
35. McGeer, P.L., and McGeer, E.G. (2001). Inflammation, autotoxicity and Alzheimer disease. Neurobiol. Aging 22, 799-809.
36. McGeer, P.L., and McGeer, E.G. (2008). Glial reactions in Parkinson's disease. Mov. Disord. 23, 474-483.
37. Morganti-Kossmann, M.C., Satgunaseelan, L., Bye, N., and Kossmann, T. (2007). Modulation of immune response by head injury. Injury 38, 1392-1400.
38. Natale, J.E., Ahmed, F., Cernak, I., Stoica, B., and Faden, A.I. (2003). Gene expression profile changes are commonly modulated across models and species after traumatic brain injury. J. Neurotrauma 20, 907-927.
39. Navab, M., Yu, R., Gharavi, N., Huang, W., Ezra, N., Lotfizadeh, A., Anantharamaiah, G.M., Alipour, N., Van Lenten, B.J., Reddy, S.T., and Marelli, D. (2007). High-density lipoprotein: antioxidant and anti-inflammatory properties. Curr. Atheroscler. Rep. 9, 244-248.
40. NINDS. (2002). National Institute of Neurological Disorders and Stroke (NINDS). Traumatic Brain Injury: Hope Through Research. NIH Publication No. 02-158. National Institutes of Health: Bethesda, MD.
41. Nishimura, M., Yaguti, H., Yoshitsugo, H., Naito, S., and Satoh, T. (2003). Tissue distribution of mRNA expression of human cytochrome P450 isoforms assessed by high-sensitivity real-time reverse transcription PCR. Yakugaku Zasshi 123, 369-375.
42. Ohyama, Y., Meaney, S., Heverin, M., Ekstrom, L., Brafman, A., Shafir, M., Andersson, U., Olin, M., Eggertsen, G., Diczfalusy, U., Feinstein, E., and Bjorkhem, I. (2006). Studies on the transcriptional regulation of cholesterol 24-hydroxylase (CYP46A1): marked insensitivity toward different regulatory axes. J. Biol. Chem. 281, 3810-3820.
43. Page, K.J., Hollister, R.D., and Hyman, B.T. (1998). Dissociation of apolipoprotein and apolipoprotein receptor response to lesion in the rat brain: an in situ hybridization study. Neuroscience 85, 1161-1171.
44. Pak, D.T., Yang, S., Rudolph-Correia, S., Kim, E., and Sheng, M. (2001). Regulation of dendritic spine morphology by SPAR, a PSD-95-associated RapGAP. Neuron 31, 289-303.
45. Pan, D.S., Liu, W.G., Yang, X.F., and Cao, F. (2007). Inhibitory effect of progesterone on inflammatory factors after experimental traumatic brain injury. Biomed. Environ. Sci. 20, 432-438.
46. Papassotiropoulous, A., Lutjohann, D., Bagli, M., Locatelli, S., Jessen, F., Buschfort, R., Ptok, U., Bjorkhem, I., von Bergmann, K., and Heun, R. (2002). 24S-Hydroxycholesterol in cerebrospinal fluid is elevated in early stages of dementia. J. Psychiatr. Res. 36, 27-32.
47. Plassman, B.L., Havlik, R.J., Steffens, D.C., Helms, M.J., Newman, T.N., Drosdick, D., Phillips, C., Gau, B.A., Welsh-Bohmer, K.A., Burke, J.R., Guralnik, J.M., and Breitner, J.C.S. (2000). Documented head injury in early adulthood and risk of Alzheimer's disease and other dementias. Neurology 55, 1158-1166.
48. Poirier, J., Hess, M., May, P.C., and Finch, C.E. (1991). Astrocytic apolipoprotein E mRNA and GFAP mRNA in hippocampus after entorhinal cortex lesioning. Brain Res. Mol. Brain Res. 11, 97-106.
49. Ramirez, D.M., Andersson, S., and Russell, D.W. (2008). Neuronal expression and subcellular localization of cholesterol 24-hydroxylase in the mouse brain. J. Comp. Neurol. 507, 1676-1693.
50. Rebeck, G.W. (2004). Induction of cholesterol efflux in the CNS. Neurobiol. Lipids 3, 1-3.
51. Reynolds, A.D., Glanzer, J.G., Kadiu, I., Ricardo-Dukelow, M., Chaudhuri, A., Ciborowski, P., Cerny, R., Gelman, B., Thomas, M.P., Mosley, R.L., and Gendelman, H.E. (2008). Nitrated alpha-synuclein-activated microglial profiling for Parkinson's disease. J. Neurochem. 104, 1504-1525.
52. Rojo, L.E., Fernandez, J.A., Maccioni, A.A., Jimenez, J.M., and Maccioni, R.B. (2008). Neuroinflammation: implications for the pathogenesis and molecular diagnosis of Alzheimer's disease. Arch. Med. Res. 39, 1-16.
53. Sanossian, N., Saver, J.L., Navab, M., and Ovbiagele, B. (2007). High-density lipoprotein cholesterol: an emerging target for stroke treatment. Stroke 38, 1104-1109.
54. Stannard, A.K., Riddell, D.R., Sacre, S.M., Tagalakis, A.D., Langer, C., von Eckardstein, A., Cullen, P., Athanasopoulos, T., Dickson, G., and Owen, J.S. (2001). Cell-derived apolipoprotein E (ApoE) particles inhibit vascular cell adhesion molecule - 1 (VCAM-1) expression in human endothelial cells. J. Biol. Chem. 276, 46011-46016.
55. Streit, W.J. (2002). Microglia as neuroprotective, immunocompetent cells of the CNS. Glia 40, 133-139.
56. Teunissen, C.E., Floris, S., Sonke, M., Dijkstra, C.D., De Vries, H.E., and Lutjohann, D. (2007). 24S-Hydroxycholesterol in relation to disease manifestations of acute experimental autoimmune encephalomyelitis. J. Neurosci. Res. 85, 1499-1505.
57. Turley, S.D., Burns, D.K., and Dietschy, J.M. (1998). Preferential utilization of newly synthesized cholesterol for brain growth in neonatal lambs. Am. J. Physiol. 274, E1099-E1105.
58. Turley, S.D., Burns, D.K., Rosenfeld, C.R., and Dietschy, J.M. (1996). Brain does not utilize low density lipoprotein-cholesterol during fetal and neonatal development in the sheep. J. Lipid Res. 37, 1953-1961.
59. Walcher, D., Kummel, A., Kehrle, B., Bach, H., Grub, M., Durst, R., Hombach, V., and Marx, N. (2006). LXR activation reduces proinflammatory cytokine expression in human CD4-positive lymphocytes. Arterioscler. Thromb. Vasc. Biol. 26, 1022-1028.
60. Whitney, K.D., Watson, M.A., Collins, J.L., Benson, W.G., Stone, T.M., Numerick, M.J., Tippin, T.K., Wilson, J.G., Winegar, D.A., and Kliewer, S.A. (2002). Regulation of cholesterol homeostasis by the liver X receptors in the central nervous system. Mol. Endocrinol. 16, 1378-1385.
61. Xie, C., Lund, E.G., Turley, S.D., Russell, D.W., and Dietschy, J.M. (2003). Quantitation of two pathways for cholesterol excretion from the brain in normal mice and mice with neurodegeneration. J. Lipid Res. 44, 1780-1789.
62. Zhang, X., Chen, Y., Jenkins, L.W., Kochanek, P.M., and Clark, R.S. (2005). Bench-to-bedside review: apoptosis/programmed cell death triggered by traumatic brain injury. Crit. Care 9, 66-75.
63. Zhang, Z., Fauser, U., and Schluesener, H.J. (2008). Early attenuation of lesional interleukin-16 up-regulation by dexamethasone and FTY720 in experimental traumatic brain injury. Neuropathol. Appl. Neurobiol. 34, 330-339.